The National Cancer Institute recognized Huntsman Cancer Institute investigator Minna Roh-Johnson for excellence in diversity, equity, inclusion, and accessibility. Roh-Johnson explains the importance of mentorship and diversity in scientific research.
A global study of a combination drug therapy, led by an investigator at Huntsman Cancer Institute, has shown improved overall survival rates for metastatic prostate cancer compared to standard treatments.
Hormone replacement therapy helps women counteract the side effects of menopause. But could it also increase the odds of getting cancer? Cindy Matsen, MD, talks through the risks and benefits.
The Princess of Wales shocked the world when she announced she was undergoing 鈥減reventative chemotherapy鈥 for cancer. We asked oncologist Heloisa Soares to help us understand this type of treatment.
Inspired by their father's battle with non-Hodgkin lymphoma, Adalyn Wood and her sisters have generated over $10,000 for cancer research with their Cookies for the Cure stand.
Demand for cancer genetic testing is on the rise, but there鈥檚 a national shortage of genetic counselors to guide patients through the process. Researchers say chatbots could be the answer.
Study shows new method forecasts the severity of a patient鈥檚 diagnosis and its likelihood of recurrence. This latest information should improve treatment and offers hope by potentially saving countless lives.
Landmark survey illustrates the care barriers that rural and frontier communities face throughout the Mountain West. This groundbreaking work helps Huntsman Cancer Institute address these disparities more effectively.
Heloisa Soares, MD, PhD, and Skyler Johnson, MD, were selected as members of The Society of Huntsman Translational Scholars for their contributions to advancing cancer research and patient care.
Early menopause significantly raises breast cancer risk, highlighting the need for proactive health screenings, according to research from Huntsman Cancer Institute and the Spencer Fox Eccles School of Medicine.
Huntsman Cancer Institute and the Price College of Engineering have selected six teams to receive collaborative grants for a new program that aims to find solutions for cancer problems.
The interdisciplinary team of lung cancer researcher Michelle Mendoza and biomedical engineer Jeffrey Weiss have received a multimillion dollar grant to study the origin of malignant tumors in the lungs.
